We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+10.87%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+486.29%
AUM
$341B
AUM Growth
+$30.7B
Cap. Flow
+$3.15B
Cap. Flow %
0.92%
Top 10 Hldgs %
10.45%
Holding
4,129
New
147
Increased
2,069
Reduced
1,601
Closed
115

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$338M
2
V icon
Visa
V
+$279M
3
MSFT icon
Microsoft
MSFT
+$277M
4
UNP icon
Union Pacific
UNP
+$277M
5
SIVB
SVB Financial Group
SIVB
+$265M

Sector Composition

Rank Sector Weight
1 Technology 17.5%
2 Healthcare 13.84%
3 Financials 13.23%
4 Industrials 11.12%
5 Consumer Discretionary 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNAC icon
3826
Cartesian Therapeutics
RNAC
$258M
$23.5K ﹤0.01%
+693
New +$29.5K
CTMX icon
3827
CytomX Therapeutics
CTMX
$750M
$21.5K ﹤0.01%
+13,461
New +$19.9K
VBIV
3828
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$21.5K ﹤0.01%
1,835
-27,214
-94% -$480K
SPRO icon
3829
Spero Therapeutics
SPRO
$71.2M
$20.9K ﹤0.01%
+12,073
New +$22.5K
PRDS
3830
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$20.5K ﹤0.01%
12,154
HLGN
3831
DELISTED
Heliogen, Inc.
HLGN
$20.4K ﹤0.01%
836
-339,944
-100% -$15.3M
DTIL icon
3832
Precision BioSciences
DTIL
$205M
$20.3K ﹤0.01%
+570
New +$22.5K
PEAR
3833
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$20K ﹤0.01%
16,920
-1,246
-7% -$2.62K
GTE icon
3834
Gran Tierra Energy
GTE
$326M
$19.8K ﹤0.01%
2,001
+26
+1% +$306
PRTK
3835
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$19.7K ﹤0.01%
+10,550
New +$26.3K
TGB
3836
Trekor Metals
TGB
$3.21B
$19.5K ﹤0.01%
13,281
VLTA
3837
DELISTED
Volta Inc.
VLTA
$19.5K ﹤0.01%
54,810
-6,092
-10% -$4.63K
STLN
3838
Starling Oncology, Inc. Common Stock
STLN
$627M
$18.4K ﹤0.01%
11,157
-1,485
-12% -$4.17K
LIDR icon
3839
AEye
LIDR
$60.9M
$18.3K ﹤0.01%
1,270
+367
+41% +$9.52K
BGRY
3840
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$18.3K ﹤0.01%
30,301
-11,473
-27% -$12.8K
WULF icon
3841
TeraWulf
WULF
$8.46B
$18.2K ﹤0.01%
27,276
SUNL
3842
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
$18.1K ﹤0.01%
703
-259,780
-100% -$7.19M
MTBL
3843
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$17.8K ﹤0.01%
11,108
-113,102
-91% -$343K
WGS icon
3844
GeneDx Holdings
WGS
$2.48B
$17.4K ﹤0.01%
1,999
+1
+0.1% +$22
WEJO
3845
DELISTED
Wejo Group Limited Common Shares
WEJO
$17.2K ﹤0.01%
35,811
+1,186
+3% +$1.06K
EIGR
3846
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$17K ﹤0.01%
482
-54
-10% -$6.49K
BRDS
3847
DELISTED
Bird Global, Inc.
BRDS
$16.4K ﹤0.01%
3,651
CIFR icon
3848
Cipher Digital
CIFR
$7.32B
$16.4K ﹤0.01%
29,241
-2,651
-8% -$2.31K
KORE
3849
DELISTED
KORE Group Holdings
KORE
$16.2K ﹤0.01%
2,570
KLR
3850
DELISTED
Kaleyra, Inc.
KLR
$15.8K ﹤0.01%
5,969

Similar funds

Invesco's Q4 2022 Portfolio in Review

As of Q4 2022, Invesco held 4,129 positions worth $341B, up 9.9% from $311B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Invesco's Q4 2022 filing shows 147 new, 2,069 increased, 1,601 reduced and 115 closed positions. Its largest new stake was British American Tobacco: 3,556,143 shares worth $142M. The largest sale was UnitedHealth, an estimated $440M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Invesco's largest Q4 2022 buy was British American Tobacco: 3,556,143 shares worth $142M.
  • Invesco added most to NVIDIA in Q4 2022, an estimated $338M increase.
  • Invesco's biggest Q4 2022 reduction was UnitedHealth, cutting an estimated $440M.
  • Invesco fully exited Duke Realty Corp. in Q4 2022, selling an estimated $131M.
  • Invesco's ten largest holdings make up 10% of its $341B portfolio in Q4 2022.
  • Invesco opened 147 new positions and closed 115 in Q4 2022.
  • Invesco's portfolio value rose 9.9% quarter-over-quarter to $341B.

Based on Invesco's 13F filing for Q4 2022, filed 13 Feb 2023.